Collectively, the results of this study highlights that BMSCs modified by XIAP can inhibit the apoptosis of brain nerve cells and the activation of astrocytes and increase the activity of AchE, so as to lower the CP caused by cerebral ischemia and hypoxia in rats. Here, ACHE is linked to brain ischemia.